Keck School of Medicine of USC
We are dedicated to promoting health, preventing and curing disease, advancing biomedical research and educating tomorrow’s physicians and scientists.
The Role of CDK4/6 in HR+ BC: 2nd, 3rd Line and Beyond, and Single-agent Abemaciclib, and Discussion of Toxicity Profiles
Comments 0
Login to view comments.
Click here to Login
